Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Etofibrate Hydrochloride
2. Lipo-merz
3. Tricerol
1. 31637-97-5
2. Etofibrate [inn]
3. 2-[2-(4-chlorophenoxy)-2-methylpropanoyl]oxyethyl Pyridine-3-carboxylate
4. Ethofibrate
5. 23tf67g79m
6. Etofibrate (inn)
7. Lipo-merz
8. 2-hydroxyethyl Nicotinate 2-(p-chlorophenoxy)-2-methylpropionate (ester)
9. Etofibrato
10. Etofibratum
11. 2-(2-(4-chlorophenoxy)-2-methylpropanoyloxy)ethyl Nicotinate
12. Etofibratum [inn-latin]
13. Etofibrato [inn-spanish]
14. Einecs 250-743-1
15. Unii-23tf67g79m
16. Etofibrate [mi]
17. Etofibrate [mart.]
18. Schembl3122
19. 3-pyridinecarboxylic Acid, 2-[2-(4-chlorophenoxy)-2-methyl-1-oxopropoxy]ethyl Ester
20. Etofibrate [who-dd]
21. Mls006010106
22. Etofibrate, Analytical Standard
23. Chembl358150
24. Dtxsid80185521
25. Chebi:135535
26. Hms3652n04
27. 2-((2-(4-chlorophenoxy)-2-methylpropanoyl)oxy)ethyl Nicotinate
28. Bcp07572
29. Hy-a0127
30. Zinc2019929
31. Mfcd00865727
32. 2-(p-chlorophenoxy)-2-methylpropionic Acid 2-(nicotinoyloxy)ethyl Ester
33. Akos025311314
34. Ccg-268206
35. Db08983
36. 121ge005
37. Ac-23121
38. As-16847
39. Smr002529563
40. Cs-0017444
41. E1359
42. Ft-0660287
43. S4264
44. Sw219681-1
45. D07187
46. T72280
47. 637e975
48. Q-201101
49. Q4116990
| Molecular Weight | 363.8 g/mol |
|---|---|
| Molecular Formula | C18H18ClNO5 |
| XLogP3 | 3.5 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 9 |
| Exact Mass | 363.0873504 g/mol |
| Monoisotopic Mass | 363.0873504 g/mol |
| Topological Polar Surface Area | 74.7 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 449 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Hypolipidemic Agents
Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. (See all compounds classified as Hypolipidemic Agents.)
Anticholesteremic Agents
Substances used to lower plasma cholesterol levels. (See all compounds classified as Anticholesteremic Agents.)
C - Cardiovascular system
C10 - Lipid modifying agents
C10A - Lipid modifying agents, plain
C10AB - Fibrates
C10AB09 - Etofibrate
ABOUT THIS PAGE
A Etofibrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Etofibrate, including repackagers and relabelers. The FDA regulates Etofibrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Etofibrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Etofibrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Etofibrate supplier is an individual or a company that provides Etofibrate active pharmaceutical ingredient (API) or Etofibrate finished formulations upon request. The Etofibrate suppliers may include Etofibrate API manufacturers, exporters, distributors and traders.
click here to find a list of Etofibrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Etofibrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Etofibrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Etofibrate GMP manufacturer or Etofibrate GMP API supplier for your needs.
A Etofibrate CoA (Certificate of Analysis) is a formal document that attests to Etofibrate's compliance with Etofibrate specifications and serves as a tool for batch-level quality control.
Etofibrate CoA mostly includes findings from lab analyses of a specific batch. For each Etofibrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Etofibrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Etofibrate EP), Etofibrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Etofibrate USP).
LOOKING FOR A SUPPLIER?
